Status:
UNKNOWN
Influenza Vaccination in Fibromyalgia Patients
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Fibromyalgia Syndrome
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Fibromyalgia is a clinical syndrome characterized by the presence of chronic widespread pain accompanied by tenderness and fatigue. Central sensitization is considered to be a major pathogenetic featu...
Detailed Description
Fifty patients with fibromyalgia and 30 healthy, age - matched controls will participate in the study. The classification of fibromyalgia will be performed by applying the 1990 ACR criteria. After s...
Eligibility Criteria
Inclusion
- Patients \>18 year old age
- Capable to sign a informed consent
- Suffering from fibromyalgia (ACR criteria)
Exclusion
- Known allergy to influenza vaccine
- Allergy to eggs
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01465477
Start Date
November 1 2011
End Date
November 1 2012
Last Update
November 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheumatology Institute, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 64239